Previous studies have demonstrated that KRT17 could promote the progression of various malignancies, such as breast cancer,34 cervical carcinoma,35, 36, 37 gastric cancer,38 non–small‐cell lung cancer39 and skin squamous carcinoma.40 The gene discussed is KRT17; the disease is gastric cancer.